59 results
425
SPRC
SciSparc Ltd
12 Apr 24
Business combination disclosure
9:23am
whose business focuses on the sale of hemp seeds oil-based products on Amazon Marketplace.
About AutoMax Motors Ltd.
AutoMax is involved in parallel
6-K
EX-99.3
SPRC
SciSparc Ltd
11 Apr 24
Agreement and Plan of Merger
4:05pm
business focuses on the sale of hemp seeds oil-based products on Amazon Marketplace.
About AutoMax Motors Ltd.
AutoMax is involved in parallel
6-K
EX-99.1
SPRC
SciSparc Ltd
27 Mar 24
SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression
9:18am
and status epilepticus. The Company also owns a controlling interest in a subsidiary whose business focuses on the sale of hemp seeds oil-based
6-K
EX-99.1
SPRC
SciSparc Ltd
15 Mar 24
SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial
8:00am
the commencement of dosing.
SciSparc’s proprietary SCI-210 treatment combines cannabidiol-rich oil (“CBD”) and CannAmide™, SciSparc’s proprietary … for the treatment of ASD and status epilepticus. The Company also owns a controlling interest in a subsidiary whose business focuses on the sale of hemp seeds oil
6-K
EX-99.2
vdkk1js 7lzmxbhb5e9
8 Mar 24
SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology
9:00am
6-K
EX-99.3
7mi912asisu
8 Mar 24
SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology
9:00am
6-K
EX-99.1
uno7spjsdi
8 Mar 24
SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology
9:00am
6-K
EX-99.1
om1a ou0cuvj1h
29 Feb 24
Report of Foreign Private Issuer
9:07am
F-1
ieba6 gdm6tsv0
27 Feb 24
Registration statement (foreign)
4:15pm
6-K
EX-99.1
436yto9r
27 Feb 24
SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds
8:35am
6-K
EX-99.1
9o3rte
20 Feb 24
SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based Compounds
4:27pm
6-K
EX-99.1
l329c tm7i
29 Jan 24
SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
4:00pm
6-K
EX-99.1
83oi5u
25 Jan 24
SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement
9:05am
6-K
EX-99.1
tzz2y1hh5ifeja1y6
22 Jan 24
SciSparc Advances the Acquisition Process of a Leading Vehicle Importer Company in Israel with the provision of a Bridge Loan of $1.4 million
6:02am
6-K
EX-99.1
n6r1l70qvcsbqfnqts
8 Dec 23
SciSparc Provides Updates Regarding the Non-Binding Letter of Intent to Acquire Leading Vehicle Importer Company in Israel
8:47am
6-K
EX-99.1
5jzyeeem
28 Nov 23
Report of Foreign Private Issuer
4:01pm
6-K
EX-99.1
f95a340e093nv9
28 Nov 23
SciSparc Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Proprietary Psychedelic-Based Treatment
4:00pm
6-K
EX-99.1
s7y6z3pod
27 Nov 23
SciSparc Announces Positive Results for MitoCareX Bio with its Drug Discovery Platform
4:00pm
6-K
EX-99.1
0ef47
22 Nov 23
SciSparc Signs Non-Binding Letter of Intent to Merge with Leading Vehicle Importer Company in Israel
4:01pm